AAAAAA
Results: 1-25/34
Authors:
Laan, RFJM
van Riel, PLCM
van de Putte, LBA
Citation: Rfjm. Laan et al., Leflunomide and methotrexate, CURR OP RH, 13(3), 2001, pp. 159-163
Authors:
Kroot, EJJA
van Gestel, AM
Swinkels, HL
Albers, MMC
van de Putte, LBA
van Riel, PLCM
Citation: Ejja. Kroot et al., Chronic comorbidity in patients with early rheumatoid arthritis: A descriptive study, J RHEUMATOL, 28(7), 2001, pp. 1511-1517
Authors:
Radstake, TRDJ
Barrera, P
Albers, MJC
Swinkels, HL
van de Putte, LBA
van Riel, PLCM
Citation: Trdj. Radstake et al., Genetic anticipation in rheumatoid arthritis in Europe, J RHEUMATOL, 28(5), 2001, pp. 962-967
Authors:
van Ede, AE
Laan, RFJM
Rood, MJ
Huizinga, TWJ
van de Laar, MAFJ
van Denderen, CJ
Westgeest, TAA
Romme, TC
de Rooij, DJRAM
Jacobs, MJM
de Boo, TM
van der Wilt, GJ
Severens, JL
Hartman, M
Krabbe, PFM
Dijkmans, BAC
Breedveld, FC
van de Putte, LBA
Citation: Ae. Van Ede et al., Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis - A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study, ARTH RHEUM, 44(7), 2001, pp. 1515-1524
Authors:
van Ede, AE
Laan, RFJM
Blom, HJ
Huizinga, TWJ
Haagsma, CJ
Giesendorf, BAJ
de Boo, TM
van de Putte, LBA
Citation: Ae. Van Ede et al., The C677T mutation in the methylenetetrahydrofolate reductase gene - A genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients, ARTH RHEUM, 44(11), 2001, pp. 2525-2530
Authors:
Barrera, P
Joosten, LAB
den Broeder, AA
van de Putte, LBA
van Riel, PLCM
van den Berg, WB
Citation: P. Barrera et al., Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNF alpha in patients with rheumatoid arthritis, ANN RHEUM D, 60(7), 2001, pp. 660-669
Authors:
Zandbelt, MM
van den Hoogen, FHJ
de Wilde, PC
van den Berg, PJS
Schneider, HGF
van de Putte, LBA
Citation: Mm. Zandbelt et al., Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjogren's syndrome, ANN RHEUM D, 60(5), 2001, pp. 511-513
Authors:
den Broeder, AA
van den Hoogen, FHJ
van de Putte, LBA
Citation: Aa. Den Broeder et al., Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment, ANN RHEUM D, 60(5), 2001, pp. 538-539
Authors:
Scott, DL
Smolen, JS
Kalden, JR
van de Putte, LBA
Larsen, A
Kvien, TK
Schattenkirchner, M
Nash, P
Oed, C
Loew-Friedrich, I
Citation: Dl. Scott et al., Treatment of active rheumatoid arthritis with leflunomide: two year followup of a double blind, placebo controlled trial versus sulfasalazine, ANN RHEUM D, 60(10), 2001, pp. 913-923
Authors:
van Heereveld, HAEM
Laan, RFJM
van den Hoogen, FHJ
Malefijt, MCD
Novakova, IRO
van de Putte, LBA
Citation: Haem. Van Heereveld et al., Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement, ANN RHEUM D, 60(10), 2001, pp. 974-976
Authors:
Barrera, P
van der Laken, CJ
Boerman, OC
Oyen, WJG
van de Ven, MTP
van Lent, PLEM
van de Putte, LBA
Corstens, FHM
Citation: P. Barrera et al., Radiolabelled interleukin-1 receptor antagonist for detection of synovitisin patients with rheumatoid arthritis, RHEUMATOLOG, 39(8), 2000, pp. 870-874
Authors:
Radstake, TRDJ
Barrera, P
Albers, JMC
Swinkels, HL
van de Putte, LBA
van Riel, PLCM
Citation: Trdj. Radstake et al., Familial vs sporadic rheumatoid arthritis (RA). A prospective study in an early RA inception cohort, RHEUMATOLOG, 39(3), 2000, pp. 267-273
Authors:
Kerstens, PJSM
Boerbooms, AMT
Jeurissen, MEC
de Graaf, R
Mulder, J
van de Putte, LBA
Citation: Pjsm. Kerstens et al., Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine, J RHEUMATOL, 27(5), 2000, pp. 1148-1155
Authors:
Rodenburg, RJT
Ganga, A
van Lent, PLEM
van de Putte, LBA
van Venrooij, WJ
Citation: Rjt. Rodenburg et al., The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis, ARTH RHEUM, 43(9), 2000, pp. 1941-1950
Authors:
Barrera, P
Blom, A
van Lent, PLEM
van Bloois, L
Beijnen, JH
van Rooijen, N
Malefijt, MCD
van de Putte, LBA
Storm, G
van den Berg, WB
Citation: P. Barrera et al., Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis, ARTH RHEUM, 43(9), 2000, pp. 1951-1959
Authors:
Kroot, EJJA
de Jong, BAW
van Leeuwen, MA
Swinkels, H
van den Hoogen, FHJ
van't Hof, M
van de Putte, LBA
van Rijswijk, MH
van Venrooij, WJ
van Riel, PLCM
Citation: Ejja. Kroot et al., The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis, ARTH RHEUM, 43(8), 2000, pp. 1831-1835
Authors:
van Lent, PLEM
van Vuuren, AJ
Blom, AB
Holthuysen, AEM
van de Putte, LBA
van de Winkel, JGJ
van den Berg, WB
Citation: Plem. Van Lent et al., Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis, ARTH RHEUM, 43(4), 2000, pp. 740-752
Authors:
Barrera, P
Balsa, A
Alves, H
Westhovens, R
Maenaut, K
Cornelis, F
Fritz, P
Bardin, T
de Almeida, G
Lopes-Vaz, A
Salcedo, DP
de la Concha, EG
Radstake, TRDJ
van de Putte, LBA
Migliorini, P
Prud'homme, JF
Charron, D
Spyropoulou, M
Mendes, A
Spaepen, M
Martinez, M
Lepage, V
Stravopoulos, C
Citation: P. Barrera et al., Noninherited maternal antigens do not play a role in rheumatoid arthritis susceptibility in Europe, ARTH RHEUM, 43(4), 2000, pp. 758-764
Authors:
de Vries, N
van Elderen, C
Tijssen, H
van Riel, PLCM
van de Putte, LBA
Citation: N. De Vries et al., Role of HLA-DQ in rheumatoid arthritis susceptibility: comment on the article by Be Vries ct al - Reply, ARTH RHEUM, 43(4), 2000, pp. 947-948
Authors:
Lipsky, PE
Brooks, P
Crofford, LJ
DuBois, R
Graham, D
Simon, LS
van de Putte, LBA
Abramson, SB
Citation: Pe. Lipsky et al., Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease, ARCH IN MED, 160(7), 2000, pp. 913-920
Authors:
Smolen, JS
Breedveld, FC
Burmester, GR
Combe, B
Emery, P
Kalden, JR
Klareskog, L
Maini, RN
Numo, R
van de Putte, LBA
van Riel, PLCM
Rodriguez-Valverde, V
Citation: Js. Smolen et al., Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis, ANN RHEUM D, 59(7), 2000, pp. 504-505
Authors:
Kroot, EJA
van Leeuwen, MA
van Rijswijk, MH
Prevoo, MLL
Van't Hof, MA
van de Putte, LBA
van Riel, PLCM
Citation: Eja. Kroot et al., No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset, ANN RHEUM D, 59(12), 2000, pp. 954-958
Authors:
Kroot, EJJA
van de Putte, LBA
van Riel, PLCM
Citation: Ejja. Kroot et al., Management of therapy-resistant rheumatoid arthritis, BEST PR R C, 13(4), 1999, pp. 737-752
Authors:
Barrera, P
Radstake, TRDJ
Albers, JMC
van Riel, PLCM
van de Putte, LBA
Citation: P. Barrera et al., Familial aggregation of rheumatoid arthritis in The Netherlands: a cross-sectional hospital-based survey, RHEUMATOLOG, 38(5), 1999, pp. 415-422
Authors:
van de Putte, LBA
Kroot, EJA
van Riel, PLCM
Citation: Lba. Van De Putte et al., Management of refractory rheumatoid arthritis, RHEUMATOLOG, 38, 1999, pp. 32-34